Trade Mark Journal No.2026/003 16 January 2026
WO0000001893961 (1,5,9)
Office of origin: United States of America
Date of International Registration:28 July 2025
Date of designation in the UK:
28 July 2025

International priority date claimed: 26 June 2025
(United States of America)
(99254492)
- Class 1
- Reagents and chemicals for scientific, medical research, clinical research, life science, laboratory, pharmaceutical research, and scientific diagnostic purposes; reagents, namely recombinant proteins and antibodies, for scientific, medical research, clinical research, life science, laboratory, pharmaceutical research, and scientific diagnostic purposes; biological cell culture material for scientific, medical research, clinical research, life science, laboratory, pharmaceutical research, and scientific diagnostic purposes; assays for research purposes; fluorescent dye for scientific, medical research, clinical research, life science, laboratory, pharmaceutical research, and scientific diagnostic purposes; oligonucleotides for scientific, medical research, clinical research, life science, laboratory, pharmaceutical research, and scientific diagnostic purposes; enzymes for scientific and research purposes.
- Class 5
- Reagents and diagnostic reagents for clinical medical use; chemicals for clinical medical use, namely, for diagnosing, detecting, prognosing, stratifying or selecting therapy for a disease condition, including cancer and inherited genetic disorders; antibodies for medical purposes; proteins for medical diagnosis purposes; oligonucleotides for medical diagnostic purposes; culture media for cultivating human and animal cells for medical or clinical use; reagents and media for medical and veterinary diagnostic purposes; biological reagents, namely, clinical medical reagents; diagnostic preparations for medical laboratory purposes through use of the western blotting technique.
- Class 9
- Instrumentation for life science research, namely, instruments to identify, quantify, and characterize proteins, analyze particles in biological samples, perform immunoassays, and to dispense and characterize cells; instrumentation for life science research, namely, instruments for quality control and analysis in the manufacture of therapeutic products; multiplexers; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in microtiter plates; microplate readers in the nature of apparatuses and instruments used to detect and measure absorbance at different light wavelengths for immunoassays; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in plates for research, bioassays, drug discovery, and manufacturing; protein analysis equipment comprised of computer hardware, software, and display screens for protein detection, imaging, and quantitative analysis for use in genetic research, antibody research, biomarker discovery, and biotherapeutics production; laboratory apparatus, namely, protein sample fractionators; computer hardware and peripherals; downloadable software for multiplexing; laboratory apparatus, namely, for western blot processing.
BIO-TECHNE CORPORATION
Representative: Courtney Thompson Fredrikson & Byron, 60 South Sixth Street,, Suite 1500, Minneapolis MN 55402, UNITED STATES OF AMERICA